Differentiation potential of CD14 + monocytes into myofibroblasts in patients with systemic sclerosis

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Binai, Nadine ^a   O'Reilly, Steven ^a   Griffiths, Bridget ^b   van Laar, Jacob M ^a   Hügle, Thomas ^a,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD14 ANTIGEN; COLLAGEN TYPE 1; ENDOTHELIN 1; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 4; ACTA2 PROTEIN, HUMAN; ACTIN;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MONOCYTE; MYOFIBROBLAST; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SYSTEMIC SCLEROSIS; UPREGULATION; CASE CONTROL STUDY; CELL CULTURE; CELL SHAPE; DRUG EFFECT; GEL; METABOLISM; MIDDLE AGED; PATHOLOGY;

ACTINS; ADULT; AGED, 80 AND OVER; ANTIGENS, CD14; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL SHAPE; CELLS, CULTURED; COLLAGEN TYPE I; ENDOTHELIN-1; FEMALE; GELS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; MALE; MIDDLE AGED; MONOCYTES; MYOFIBROBLASTS; PHENOTYPE; SCLERODERMA, SYSTEMIC; UP-REGULATION;

EID: 84858163271     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033508     Document Type: Article

References (29)

1. Varga J, Abraham D, (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117: 557-67.
2. Manetti M, Neumann E, Milia AF, Tarner IH, Bechi P, et al. (2007) Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients. Arthritis Rheum 56: 3442-7.
3. Kraling BM, Maul GG, Jimenez SA, (1995) Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages. Pathobiology 63: 48-56.
4. Reilkoff RA, Bucala R, Herzog EL, (2011) Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol 11: 427-35.
5. Zhao Y, Glesne D, Huberman E, (2003) A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 100: 2426-31.
6. Higashi-Kuwata N, Jinnin M, Makino T, Fukushima S, Inoue Y, et al. (2010) Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther 12: R128.
7. Mathai SK, Gulati M, Peng X, Russell TR, Shaw AC, et al. (2010) Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest 90: 812-23.
8. York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R, (2007) A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis Rheum 56: 1010-20.
9. Tourkina E, Bonner M, Oates J, Hofbauer A, Richard M, et al. (2011) Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis Tissue Repair 4: 15.
10. Katebi M, Fernandez P, Chan ES, Cronstein BN, (2008) Adenosine A2A receptor blockade or deletion diminishes fibrocyte accumulation in the skin in a murine model of scleroderma, bleomycin-induced fibrosis. Inflammation 31: 299-303.
11. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G, (1993) Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103-11.
12. Shahar I, Fireman E, Topilsky M, Grief J, Schwarz Y, et al. (1999) Effect of endothelin-1 on alpha-smooth muscle actin expression and on alveolar fibroblasts proliferation in interstitial lung diseases. Int J Immunopharmacol 21: 759-75.
13. Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, et al. (2005) Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166: 1321-32.
14. Bucala R, (2008) Circulating fibrocytes: cellular basis for NSF. J Am Coll Radiol 5: 36-9.
15. Libby P, (2002) Inflammation in atherosclerosis. Nature 420: 868-74.
16. Conti L, Gessani S, (2008) GM-CSF in the generation of dendritic cells from human blood monocyte precursors: recent advances. Immunobiology 213: 859-70.
17. Sallerfors B, (1994) Endogenous production and peripheral blood levels of granulocyte-macrophage [GM-] and granulocyte [G-] colony-stimulating factors. Leuk Lymphoma 13: 235-47.
18. Akagawa KS, (2002) Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages. Int J Hematol 76: 27-34.
19. Chitta S, Santambrogio L, Stern LJ, (2008) GMCSF in the absence of other cytokines sustains human dendritic cell precursors with T cell regulatory activity and capacity to differentiate into functional dendritic cells. Immunol Lett 116: 41-54.
20. Xing Z, Tremblay GM, Sime PJ, Gauldie J, (1997) Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation. Am J Pathol 150: 59-66.
21. Cebon J, Layton J, (1994) Measurement and clinical significance of circulating hematopoietic growth factor levels. Curr Opin Hematol 1: 228-34.
22. Ashitani J, Mukae H, Taniguchi H, Ihi T, Kadota J, et al. (1999) Granulocyte-colony stimulating factor levels in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis. Thorax 54: 1015-20.
23. Postiglione L, Montagnani S, Riccio A, Montuori N, Sciorio S, et al. (2002) Enhanced expression of the receptor for granulocyte macrophage colony stimulating factor on dermal fibroblasts from scleroderma patients. J Rheumatol 29: 94-101.
24. Hermes B, Welker P, Feldmann-Boddeker I, Kruger-Krasagakis S, Hartmann K, et al. (2001) Expression of mast cell growth modulating and chemotactic factors and their receptors in human cutaneous scars. J Invest Dermatol 116: 387-93.
25. Shi-Wen X, Chen Y, Denton CP, Eastwood M, Renzoni EA, et al. (2004) Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 15: 2707-19.
26. Tabata H, Yamakage A, Yamazaki S, (1997) Cutaneous localization of endothelin-1 in patients with systemic sclerosis: immunoelectron microscopic study. Int J Dermatol 36: 272-5.
27. Sheridan CM, Occleston NL, Hiscott P, Kon CH, Khaw PT, Grierson I, (2001) Matrix metalloproteinases: a role in the contraction of vitreo-retinal scar tissue. Am J Pathol 159: 1555-66.
28. Saito A, Okazaki H, Sugawara I, Yamamoto K, Takizawa H, (2003) Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int Arch Allergy Immunol 132: 168-76.
29. Shephard P, Hinz B, Smola-Hess S, Meister JJ, Krieg T, Smola H, (2004) Dissecting the roles of endothelin, TGF-beta and GM-CSF on myofibroblast differentiation by keratinocytes. Thromb Haemost 92: 262-74.